These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28709123)

  • 1. Subclinical white matter lesions and medial temporal lobe atrophy are associated with EEG slowing in a memory clinic cohort.
    Kramberger MG; Giske K; Cavallin L; Kåreholt I; Andersson T; Winblad B; Jelic V
    Clin Neurophysiol; 2017 Sep; 128(9):1575-1582. PubMed ID: 28709123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.
    Claus JJ; Coenen M; Staekenborg SS; Schuur J; Tielkes CEM; Koster P; Scheltens P
    J Alzheimers Dis; 2018; 63(3):1129-1139. PubMed ID: 29710708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
    Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
    J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementia.
    Pleizier CM; van der Vlies AE; Koedam E; Koene T; Barkhof F; van der Flier WM; Scheltens P; Pijnenburg Y
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1145-8. PubMed ID: 22933816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease.
    García-Alberca JM; Florido M; Cáceres M; Sánchez-Toro A; Lara JP; García-Casares N
    Psychogeriatrics; 2019 Jan; 19(1):46-54. PubMed ID: 30084177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-cognitive mechanisms of simultanagnosia in patients with posterior cortical atrophy.
    Neitzel J; Ortner M; Haupt M; Redel P; Grimmer T; Yakushev I; Drzezga A; Bublak P; Preul C; Sorg C; Finke K
    Brain; 2016 Dec; 139(Pt 12):3267-3280. PubMed ID: 27702740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Saka E; Dogan EA; Topcuoglu MA; Senol U; Balkan S
    Arch Gerontol Geriatr; 2007; 44(2):141-51. PubMed ID: 16723158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Visual Magnetic Resonance Rating Scale for Evaluation of Patients with Forgetfulness.
    Yalciner BZ; Kandemir M; Taskale S; Tepe SM; Unay D
    Can J Neurol Sci; 2019 Jan; 46(1):71-78. PubMed ID: 30417801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy.
    Swardfager W; Cogo-Moreira H; Masellis M; Ramirez J; Herrmann N; Edwards JD; Saleem M; Chan P; Yu D; Nestor SM; Scott CJM; Holmes MF; Sahlas DJ; Kiss A; Oh PI; Strother SC; Gao F; Stefanovic B; Keith J; Symons S; Swartz RH; Lanctôt KL; Stuss DT; Black SE
    Neurology; 2018 Feb; 90(8):e673-e682. PubMed ID: 29374101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors.
    Akinyemi RO; Firbank M; Ogbole GI; Allan LM; Owolabi MO; Akinyemi JO; Yusuf BP; Ogunseyinde O; Ogunniyi A; Kalaria RN
    BMC Res Notes; 2015 Oct; 8():625. PubMed ID: 26519155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
    Korf ES; Scheltens P; Barkhof F; de Leeuw FE
    Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.
    Torisson G; van Westen D; Stavenow L; Minthon L; Londos E
    BMC Geriatr; 2015 Jun; 15():65. PubMed ID: 26076825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Cerebral Atrophy Detected by Routine Imaging: Relationship with Age, Hippocampal Atrophy, and White Matter Hyperintensities.
    Al-Janabi OM; Panuganti P; Abner EL; Bahrani AA; Murphy R; Bardach SH; Caban-Holt A; Nelson PT; Gold BT; Smith CD; Wilcock DM; Jicha GA
    J Neuroimaging; 2018 May; 28(3):301-306. PubMed ID: 29314393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients].
    Tokuchi R; Deguchi K; Yamashita T; Abe K
    Nihon Ronen Igakkai Zasshi; 2014; 51(4):342-9. PubMed ID: 25327368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Prevalence of Mixed Dementia in a Cohort of 2,000 Elderly Patients in a Memory Clinic Setting.
    Claus JJ; Staekenborg SS; Roorda JJ; Stevens M; Herderschee D; van Maarschalkerweerd W; Schuurmans L; Tielkes CE; Koster P; Bavinck C; Scheltens P
    J Alzheimers Dis; 2016; 50(3):797-806. PubMed ID: 26757192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
    Jokinen H; Lipsanen J; Schmidt R; Fazekas F; Gouw AA; van der Flier WM; Barkhof F; Madureira S; Verdelho A; Ferro JM; Wallin A; Pantoni L; Inzitari D; Erkinjuntti T;
    Neurology; 2012 May; 78(22):1785-92. PubMed ID: 22592361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.